Autopsy report · NCT06003179

Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“recruitment challenges and sites who initially expressed interest declined.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: University Health Network, Toronto
Sponsor type: University, hospital or other
Conditions: Lymphoma, Large B-Cell, Diffuse
Interventions: Cyclophosphamide; TLI; Fludarabine
Participants: 0
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.